✦ LIBER ✦

PMH11 PROBABILISTIC COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN THE TREATMENT OF SEVERE DEPRESSION IN THE UNITED KINGDOM

✍ Scribed by ME Hemels; I Toumi; AG Wade

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH29 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ ME Hemels; S Kasper; E Walter; T Enron 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH9 A PROBABILISTIC COST-EFFECTIVENESS

✍ ME Hemels; I Toumi; AG Wade 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PMH46 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ W Kulp; M Hemels; W Greiner; J Schulenburg Graf von der 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ ME Hemels; O Karamustafaloglu; E Ozmen; S Dilsad; S Mene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH28 A COST-EFFECTIVENESS ANALYSIS OF E

✍ EP Armstrong; GH Skrepnek; DC Malone; H Erder 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PMH60 A PHARMACOECONOMIC COMPARISON OF E

✍ AG Wade; JL Fernandez; C François; K Hansen; N Despiegel; N Danchenko 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB